Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.
25 May 2023 -- Massachusetts, US -- In response to the data management needs of laboratories worldwide, Labbit emerges as a game-changer in the industry. Unlike any other LIMS platforms available, Labbit has been built as FAIR from the ground up and so data is findable, accessible, interoperable and reusable from day one.
24 May 2023 -- London, UK -- Automata, a leading company powering life science labs to fully automate their workflows, today launches LINQ Cloud: cutting-edge laboratory automation software. LINQ Cloud connects a lab’s physical and digital environment together, enabling life science organisations to scale while reducing the manual workload for scientists.
24 May 2023 -- Massachusetts, US -- Laboratory digital transformation pioneer, Scitara, announces new releases to its SOC 2-certified Digital Lab Exchange DLX cloud platform to improve the user experience, enhance instrument connectivity and deliver new automation to the lab.
23 May 2023 -- Cardiff, UK -- CatSci, an award-winning innovation partner for medicines development, are proud to announce the launch of their new and improved SmartPath. SmartPath is an innovative digital risk assessment tool that highlights the risks de-railing users’ API success and offers tailored Smart mitigation strategies on the project, formulation and API properties.
23 May 2023 -- Cambridge, UK -- Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced the introduction of new branding to align with its ambitious global commercial growth strategy.
22 May 2023 -- Hyderabad, India -- Aurigene Pharmaceutical Services, a contract research, development and manufacturing services organisation and a step-down subsidiary of Dr Reddy's Laboratories, announces the construction of a state-of-the art development and manufacturing facility for therapeutic proteins, antibodies and viral vectors.
18 May 2023 -- Massachusetts, US -- Revvity today announced a new license agreement with AstraZeneca for the technology underlying its Pin-point base editing system, a next-generation modular gene editing platform with a strong safety profile.
17 May 2023 -- Cambridge, UK -- Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced that it had won an award from the US Defense Innovation Unit (DIU), a division of the US Department of Defence (DoD), for ‘Exhaled Breath Diagnostics’.
17 May 2023 -- London and Basildon, UK -- Closed Loop Medicine, a leading TechBio company, developing combination prescription drug plus software therapy products that enable personalised dose optimisation, and Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines, today announced that they have entered a global co-development partnership.
17 May 2023 -- Pennsylvania, US -- Alliance Pharma, a global leader providing bioanalytical, DMPK and CMC testing services in the pharmaceutical and biopharmaceutical industry, and Drug Development Solutions, (acquired in 2022), today announced they will be operating under the new name Resolian – fully integrating the companies into one organisation.
17 May 2023 -- Maryland, US -- Artificial intelligence (AI) has been fundamental to the development of Novavax’s COVID-Influenza Combination (CIC) vaccine, reflecting a wider industry trend for increased usage of AI in clinical trial design, says GlobalData, a leading data and analytics company.
15 May 2023 -- Massachusetts, US -- Nido Biosciences, a clinical stage company developing precision medicines for debilitating neurological diseases, emerged from stealth today backed by an industry leading investor syndicate and having raised a combined $109m in Seed, Series A and B financings. Nido Bio was founded through the 4:59 Initiative at 5AM Ventures.